1 / 16

AMASA-9 Meeting, Addis Ababa, 10 - 12 th November 2013

Stimulating the Bio-Economy in Africa. M. Iqbal Parker Academy of Science of South Africa Director: ICGEB Cape Town. AMASA-9 Meeting, Addis Ababa, 10 - 12 th November 2013. Biotechnology Sectors in Emerging Markets. ALL Biotechnologies. Conventional Biotechnology. Trypsin. Recombinant

axel-walter
Télécharger la présentation

AMASA-9 Meeting, Addis Ababa, 10 - 12 th November 2013

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Stimulating the Bio-Economy in Africa M. Iqbal Parker Academy of Science of South Africa Director: ICGEB Cape Town AMASA-9 Meeting, Addis Ababa, 10 - 12th November 2013

  2. Biotechnology Sectors in Emerging Markets

  3. ALL Biotechnologies

  4. Conventional Biotechnology Trypsin Recombinant Pro Insulin Recombinant Insulin

  5. ICGEB: an intergovernmental organization Trieste, Italy New Delhi, India CapeTown, South Africa 80+ Signatory States, 60+ Member States, 3 Components: Trieste (Italy) - New Delhi (India) - CapeTown (South Africa) and a network of 40+ Affiliated Centres Developing knowledge

  6. Production of Bio-Similars

  7. What does the International Centre for Genetic Engineering and Biotechnology offer ?

  8. INSTRUMENTSOF ACTION Member Country Research Laboratories Workshops and Courses Pre- and Post-Doc Fellowships (€ 18,000) (€ 20,000) ICGEB Components Basic and Applied Research Institutional and Scientific Services Trained Scientists Technology Transfer Research Grants Member Country Research Laboratories (€ 30,000)

  9. Technology Transfer opportunities • Recombinant Human Interferons • Recombinant Human erythropoietin • Recombinant Human Insulin • Recombinant Human GCSF • Pegylated Interferon • Pegylation Reagent • Etc

  10. What should be done ?

  11. A RESEARCH, DEVELOPMENT AND INNOVATION STRATEGY TO STRENGTHEN THE BIOECONOMY DRAFT DOCUMENT

  12. Thank You International Centre for Genetic Engineering and Biotechnology

More Related